Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CXSL2500587	QL2107注射液	pembrolizumab	Injection	Biological Products(2.2)	New Drug Application	2025-07-14	QILU Pharmaceutical Co Ltd	view
JXSS2500074	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500092	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view
JXSS2500075	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500095	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view
JXSS2500093	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view
JXSS2500079	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500086	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500076	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500087	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view
JXSS2500090	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500082	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500078	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view
JXSS2500085	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view
JXSS2500083	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500091	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500080	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500084	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500081	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV	view
JXSS2500088	帕博利珠单抗注射液（皮下注射）	pembrolizumab	Injection	Biological Products(2.1)	Import Drug Application	2025-06-12	BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd	view